Page last updated: 2024-08-21

cyclopentane and Leukemia, Promyelocytic, Acute

cyclopentane has been researched along with Leukemia, Promyelocytic, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Andricopulo, AD; Barroso de Oliveira, AS; Coelho, F; Costa-Lotufo, LV; da Silva, JCL; Dos Santos, RN; Fernandes, DC; Gomes, RDC; Lima, K; Machado-Neto, JA; Rodrigues Junior, MT; Vicari, HP	1

Other Studies

1 other study(ies) available for cyclopentane and Leukemia, Promyelocytic, Acute

Article	Year
Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells. European journal of pharmacology, 2021, Mar-05, Volume: 894 Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclopentanes; DNA Damage; Drug Resistance, Neoplasm; Humans; Indoles; Leukemia, Promyelocytic, Acute; Microtubules; Mitosis; Models, Molecular; Stathmin; Tumor Stem Cell Assay	2021

Article

Year

Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells.

European journal of pharmacology, 2021, Mar-05, Volume: 894

Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclopentanes; DNA Damage; Drug Resistance, Neoplasm; Humans; Indoles; Leukemia, Promyelocytic, Acute; Microtubules; Mitosis; Models, Molecular; Stathmin; Tumor Stem Cell Assay

2021